Evidence map›Paper›PMID 39269114›Full record

ArticleNanomaterials (Basel, Switzerland)2024

The Influence of Silver-Containing Bionanomaterials Based on Humic Ligands on Biofilm Formation in Opportunistic Pathogens.

Maria V Zykova, Maria R Karpova, Yu Zhang, Marianna V Chubik, Daria M Shunkova, Lyudmila A Azarkina, Dmitrii A Mihalyov, Andrey I Konstantinov, Evgenii V Plotnikov, Alexey N Pestryakov and 2 more

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maria V ZykovaPharmaceutical Faculty, Siberian State Medical University, Tomsk 634050, Russia.
Maria R KarpovaPharmaceutical Faculty, Siberian State Medical University, Tomsk 634050, Russia.
Yu ZhangDepartment of Chemistry, Lomonosov Moscow State University, Leninskiye Gory 1-3, Moscow 119991, Russia.ORCID 0009-0004-1578-882X
Marianna V ChubikPharmaceutical Faculty, Siberian State Medical University, Tomsk 634050, Russia.
Daria M ShunkovaPharmaceutical Faculty, Siberian State Medical University, Tomsk 634050, Russia.
Lyudmila A AzarkinaPharmaceutical Faculty, Siberian State Medical University, Tomsk 634050, Russia.
Dmitrii A MihalyovPharmaceutical Faculty, Siberian State Medical University, Tomsk 634050, Russia.
Andrey I KonstantinovDepartment of Chemistry, Lomonosov Moscow State University, Leninskiye Gory 1-3, Moscow 119991, Russia.ORCID 0000-0001-7491-3820
Evgenii V PlotnikovResearch School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk 634050, Russia.
Alexey N PestryakovResearch School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk 634050, Russia.ORCID 0000-0002-9034-4733
Irina V PerminovaDepartment of Chemistry, Lomonosov Moscow State University, Leninskiye Gory 1-3, Moscow 119991, Russia.
Mikhail V BelousovPharmaceutical Faculty, Siberian State Medical University, Tomsk 634050, Russia.ORCID 0000-0002-2153-7945

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The uncontrolled use of antibiotics has led to a global problem of antimicrobial resistance. One of the main mechanisms of bacterial resistance is the formation of biofilms. In order to prevent the growth of antimicrobial resistance, it is crucial to develop new antibacterial agents that are capable of inhibiting the formation of biofilms. This makes this area of research highly relevant today. Promising candidates for these antibacterial agents are new bionanomaterials made from natural humic substances and silver nanoparticles. These substances have the potential to not only directly kill microorganisms but also penetrate biofilms and inhibit their formation. The goal of this study is to synthesize active pharmaceutical substances in the form of bionanomaterials, using ultradispersed silver nanoparticles in a matrix of coal humic substances, perform their characterization (NMR spectroscopy, TEM, and ICP-AES methods), and research their influence on biofilm formation in the most dangerous opportunistic pathogens (

Indexed as

antibacterial activitybiofilm formationhumic substancesopportunistic pathogensphenol–humic derivativessilver nanoparticles

Identifiers

PMID39269114
PMCPMC11397557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.